🚀 VC round data is live in beta, check it out!
Huaxia Eye Hospital Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Huaxia Eye Hospital Group and similar public comparables like Dr. Soliman Abdul Kader, MLP Sağlık, Select Medical, Akdital and more.
Huaxia Eye Hospital Group Overview
About Huaxia Eye Hospital Group
Huaxia Eye Hospital Group Co Ltd is a ophthalmic medical chain group in China. It offers ophthalmology specialist medical services.
Founded
2004
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$2B
Huaxia Eye Hospital Group Financials
Huaxia Eye Hospital Group reported last fiscal year revenue of $590M and EBITDA of $135M.
In the same fiscal year, Huaxia Eye Hospital Group generated $261M in gross profit, $135M in EBITDA, and $63M in net income.
Revenue (LTM)
Huaxia Eye Hospital Group P&L
In the most recent fiscal year, Huaxia Eye Hospital Group reported revenue of $590M and EBITDA of $135M.
Huaxia Eye Hospital Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $590M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $261M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 44% | XXX | XXX | XXX |
| EBITDA | — | XXX | $135M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 23% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 16% | XXX | XXX | XXX |
| Net Profit | — | XXX | $63M | XXX | XXX | XXX |
| Net Margin | — | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Huaxia Eye Hospital Group Stock Performance
Huaxia Eye Hospital Group has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Huaxia Eye Hospital Group's stock price is $2.50.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -1.1% | XXX | XXX | XXX | $0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHuaxia Eye Hospital Group Valuation Multiples
Huaxia Eye Hospital Group trades at 2.8x EV/Revenue multiple, and 12.5x EV/EBITDA.
EV / Revenue (LTM)
Huaxia Eye Hospital Group Financial Valuation Multiples
As of April 18, 2026, Huaxia Eye Hospital Group has market cap of $2B and EV of $2B.
Equity research analysts estimate Huaxia Eye Hospital Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Huaxia Eye Hospital Group has a P/E ratio of 33.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 12.5x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 18.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 6.4x | XXX | XXX | XXX |
| P/E | — | XXX | 33.4x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 21.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Huaxia Eye Hospital Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Huaxia Eye Hospital Group Margins & Growth Rates
Huaxia Eye Hospital Group's revenue in the last fiscal year grew by 0%.
Huaxia Eye Hospital Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (21%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 14% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 12% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Huaxia Eye Hospital Group Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Huaxia Eye Hospital Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Dr. Soliman Abdul Kader | XXX | XXX | XXX | XXX | XXX | XXX |
| MLP Sağlık | XXX | XXX | XXX | XXX | XXX | XXX |
| Select Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Akdital | XXX | XXX | XXX | XXX | XXX | XXX |
| Siloam Hospitals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Huaxia Eye Hospital Group M&A Activity
Huaxia Eye Hospital Group acquired XXX companies to date.
Last acquisition by Huaxia Eye Hospital Group was on XXXXXXXX, XXXXX. Huaxia Eye Hospital Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Huaxia Eye Hospital Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHuaxia Eye Hospital Group Investment Activity
Huaxia Eye Hospital Group invested in XXX companies to date.
Huaxia Eye Hospital Group made its latest investment on XXXXXXXX, XXXXX. Huaxia Eye Hospital Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Huaxia Eye Hospital Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Huaxia Eye Hospital Group
| When was Huaxia Eye Hospital Group founded? | Huaxia Eye Hospital Group was founded in 2004. |
| Where is Huaxia Eye Hospital Group headquartered? | Huaxia Eye Hospital Group is headquartered in China. |
| Is Huaxia Eye Hospital Group publicly listed? | Yes, Huaxia Eye Hospital Group is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group trades under 301267 ticker. |
| When did Huaxia Eye Hospital Group go public? | Huaxia Eye Hospital Group went public in 2022. |
| Who are competitors of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group main competitors are Dr. Soliman Abdul Kader, MLP Sağlık, Select Medical, Akdital. |
| What is the current market cap of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group's current market cap is $2B. |
| What is the current revenue of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group's last fiscal year revenue is $590M. |
| What is the current EV/Revenue multiple of Huaxia Eye Hospital Group? | Current revenue multiple of Huaxia Eye Hospital Group is 2.8x. |
| Is Huaxia Eye Hospital Group profitable? | No, Huaxia Eye Hospital Group is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.